Gender disparities in optimal lipid control among patients with coronary artery disease

Chun-Yen Chen1, Shao-Yuan Chuang, Ching-Chang Fang

  • 1Cardiovascular Division, Department of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College.

Insights

Coronary heart disease (CHD) affects both genders, with hypercholesterolemia being a key risk factor. This review explores gender disparities in lipid management to improve treatment outcomes for all patients.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality.
  • Hypercholesterolemia is a significant risk factor for CHD development.
  • Statins are proven effective for CHD prevention, with some evidence suggesting equal or greater efficacy in women.

Purpose of the Study:

  • To explain gender differences in lipid control among individuals with or at risk of CHD.
  • To raise awareness of gender disparities in lipid management.
  • To identify strategies for narrowing these disparities.

Main Methods:

  • Review of existing literature on lipid management and gender differences in CHD.
  • Analysis of observational studies reporting on lipid goal attainment.
  • Synthesis of evidence regarding statin efficacy in men versus women.

Main Results:

  • Observational studies indicate a significant gender gap in achieving lipid goals according to primary care guidelines.
  • Despite potential equal or greater statin effectiveness in women, they experience disparities in lipid control.
  • Understanding these differences is crucial for effective CHD prevention.

Conclusions:

  • Gender disparities in lipid management for CHD persist.
  • Further research and targeted interventions are needed to address these gaps.
  • Improving lipid control in women is essential for reducing CHD mortality.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493